EW Edwards Lifesciences Corp NYSE · United States

Edwards Lifesciences (EW) news

Edwards Lifesciences Corp is a public biotech or pharmaceutical company listed on NYSE under the ticker EW, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Edwards Lifesciences news

We have not published a story on Edwards Lifesciences yet. When there is news, it will appear here.

Edwards Lifesciences annual financials

Line	FY2025	FY2024
Revenue	$6.07 billion	$5.44 billion
Research and development	$1.08 billion	$1.05 billion
Net income (loss)	$1.07 billion	$4.17 billion
Cash from operations	$1.60 billion	$542.3 million
Cash and equivalents	$2.94 billion	$3.05 billion
Short-term investments	$1.29 billion	$930.7 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $2.91 billion, plus short-term investments of $1.35 billion, $4.25 billion in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Edwards Lifesciences

What is the ticker symbol of Edwards Lifesciences?

Edwards Lifesciences Corp trades under the ticker EW on NYSE.

Where is Edwards Lifesciences listed?

Edwards Lifesciences Corp is listed on NYSE.

Which country or territory is Edwards Lifesciences listed under?

Our directory records Edwards Lifesciences Corp under United States.

Does aibio.space cover Edwards Lifesciences?

aibio.space lists Edwards Lifesciences Corp among 2,820 public biotech companies and publishes its news here as stories appear.

What was Edwards Lifesciences's revenue last year?

$6.07 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Edwards Lifesciences profitable?

Edwards Lifesciences Corp reported net income of $1.07 billion for the fiscal year ended Dec 31, 2025, and generated $1.60 billion of cash from operations, per its annual report to the SEC.

How much does Edwards Lifesciences spend on research and development?

$1.08 billion in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Edwards Lifesciences have?

$4.25 billion in cash and short-term investments at Jun 30, 2026, per its 10-Q.

Investor discussion: Edwards Lifesciences

Members talk about Edwards Lifesciences (EW). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:EW on TradingView.

Listing details

Company: Edwards Lifesciences Corp
Ticker: EW
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction